王晓燕, 张春春. 核磁共振内标法测定达美康药片中格列齐特含量[J]. 实验科学与技术, 2022, 20(3): 7-10, 20. DOI: 10.12179/1672-4550.20200603
引用本文: 王晓燕, 张春春. 核磁共振内标法测定达美康药片中格列齐特含量[J]. 实验科学与技术, 2022, 20(3): 7-10, 20. DOI: 10.12179/1672-4550.20200603
WANG Xiaoyan, ZHANG Chunchun. Determination of Gliclazide in Dameikang Tablets by Internal Standard Method of Nuclear Magnetic Resonance[J]. Experiment Science and Technology, 2022, 20(3): 7-10, 20. DOI: 10.12179/1672-4550.20200603
Citation: WANG Xiaoyan, ZHANG Chunchun. Determination of Gliclazide in Dameikang Tablets by Internal Standard Method of Nuclear Magnetic Resonance[J]. Experiment Science and Technology, 2022, 20(3): 7-10, 20. DOI: 10.12179/1672-4550.20200603

核磁共振内标法测定达美康药片中格列齐特含量

Determination of Gliclazide in Dameikang Tablets by Internal Standard Method of Nuclear Magnetic Resonance

  • 摘要: 通过建立1H-NMR 核磁共振定量法测定达美康药片中的格列齐特含量的实验方法。采用 Bruker AVANCE II 400 型核磁共振谱仪,以对苯二甲酸二甲酯为内标,氘代氯仿为溶剂,通过格列齐特标准品和对苯二甲酸二甲酯建立了实验参数,绘制了标准曲线并进行了精密度研究。用此实验参数测定了达美康药片中有效成分格列齐特的含量,结果与说明书中含量和HPLC法含量测试结果吻合。该文建立的核磁定量的方法准确、快速,为达美康药片中的格列齐特质量控制和对照品的标定提供了新的方法。

     

    Abstract: An experimental method for determination of the content of gliclazide in Dameikang by 1H-NMR was established. With dimethyl terephthalate as internal standard substance and deuterated chloroform as solvent, the experimental parameters were established through gliclazide standard substance and dimethyl terephthalate under a Bruker AVANCE II 400 nuclear magnetic resonance spectrometer. The standard curve was drawn and the precision was studied. The content of gliclazide in Dameikang was determined by this experimental parameter. It turned out the experimental results were consistent with the contents in the manual and results by HPLC. The method established in this paper is accurate and rapid, which provides a new method for the quality control and reference material calibration of this variety.

     

/

返回文章
返回